WHOLESALE DRUG LICENSE-VARIOUS Senate SponsorsSen. Emil Jones, III House Sponsors(Rep. Theresa Mah) 5/13/2022SenatePublic Act . . . . . . . . . 102-0879 5 ILCS 80/4.335 ILCS 80/4.38225 ILCS 120/15from Ch. 111, par. 8301-15225 ILCS 120/15.5 new225 ILCS 120/21 new225 ILCS 120/27225 ILCS 120/30from Ch. 111, par. 8301-30225 ILCS 120/31 new225 ILCS 120/35from Ch. 111, par. 8301-35225 ILCS 120/40from Ch. 111, par. 8301-40225 ILCS 120/50from Ch. 111, par. 8301-50225 ILCS 120/57225 ILCS 120/70from Ch. 111, par. 8301-70225 ILCS 120/75from Ch. 111, par. 8301-75225 ILCS 120/80from Ch. 111, par. 8301-80225 ILCS 120/85from Ch. 111, par. 8301-85225 ILCS 120/100from Ch. 111, par. 8301-100225 ILCS 120/105from Ch. 111, par. 8301-105225 ILCS 120/110from Ch. 111, par. 8301-110225 ILCS 120/115from Ch. 111, par. 8301-115225 ILCS 120/120from Ch. 111, par. 8301-120225 ILCS 120/125from Ch. 111, par. 8301-125225 ILCS 120/135from Ch. 111, par. 8301-135225 ILCS 120/140from Ch. 111, par. 8301-140225 ILCS 120/155from Ch. 111, par. 8301-155225 ILCS 120/165from Ch. 111, par. 8301-165225 ILCS 120/200225 ILCS 120/3 rep.Amends the Regulatory Sunset Act. Repeals the Wholesale Drug Distribution Licensing Act on January 1, 2028 (instead of January 1, 2023). Amends the Wholesale Drug Distribution Licensing Act. Defines "address of record", "email address of record", and "suspicious order". Changes the definition of "wholesale drug distributor". Provides that applicants and licensees must provide a valid address and email address to the Department of Financial and Professional Regulation and must inform the Department of any change of these within 14 days. Provides that each licensee required to report suspicious orders shall submit such report to the Department. Provides that an individual taxpayer identification number or other unique identifying number (instead of only a social security number) may be included on the application for an original license and the application shall be made in writing or electronically and accompanied by the required, nonrefundable fee. Provides that any licensee who engages in the practice for which the license was issued while the license is expired shall be considered to be practicing without a license, which is grounds for discipline. Removes provisions that provide that: the Department shall present to the State Board of Pharmacy for review all appropriation requests from the Illinois State Pharmacy Disciplinary Fund; the Department shall maintain a roster of the names and addresses of all registrants and all persons whose licenses have been suspended or revoked; and rules that set detailed standards for meeting each license prerequisite requirements shall be adopted no later than September 14, 1992. Provides that the written notice of disciplinary hearing may be served by email or physical mail to the respondent's email address of record or address of record. Provides that the Department may subpoena and compel the relevant documents in connection with any hearing. Provides that if the Secretary of Financial and Professional Regulation disagrees with the recommendation of the Board or hearing officer, the Secretary may issue an order in contravention of the recommendation. Provides that the sanctions imposed upon the accused by the Department shall remain in full force and effect in order to protect the public pending final resolution of the proceedings. Repeals a provision concerning references to the Department or Director of Professional Regulation. Makes corresponding and other changes. Provisions amending the Regulatory Sunset Act are effective immediately. Senate Floor Amendment No. 1 Provides that "wholesale drug distributor" does not include virtual wholesalers or virtual distributors. 1/21/2022SenateFiled with Secretary by Sen. Emil Jones, III 1/21/2022SenateFirst Reading 1/21/2022SenateReferred to Assignments 2/1/2022SenateAssigned to Licensed Activities 2/10/2022SenateDo Pass Licensed Activities; 008-000-000 2/10/2022SenatePlaced on Calendar Order of 2nd Reading February 15, 2022 2/18/2022SenateSenate Floor Amendment No. 1 Filed with Secretary by Sen. Emil Jones, III 2/18/2022SenateSenate Floor Amendment No. 1 Referred to Assignments 2/22/2022SenateSenate Floor Amendment No. 1 Assignments Refers to Licensed Activities 2/23/2022SenateSecond Reading 2/23/2022SenatePlaced on Calendar Order of 3rd Reading February 24, 2022 2/23/2022SenateSenate Floor Amendment No. 1 Recommend Do Adopt Licensed Activities; 008-000-000 2/24/2022SenateRecalled to Second Reading 2/24/2022SenateSenate Floor Amendment No. 1 Adopted; Jones 2/24/2022SenatePlaced on Calendar Order of 3rd Reading 2/24/2022SenateThird Reading - Passed; 055-000-000 2/25/2022HouseArrived in House 2/28/2022HouseChief House Sponsor Rep. Theresa Mah 3/1/2022HouseFirst Reading 3/1/2022HouseReferred to Rules Committee 3/7/2022HouseAssigned to Prescription Drug Affordability & Accessibility Committee 3/16/2022HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 012-008-000 3/17/2022HousePlaced on Calendar 2nd Reading - Short Debate 3/23/2022HouseSecond Reading - Short Debate 3/23/2022HousePlaced on Calendar Order of 3rd Reading - Short Debate 4/1/2022HouseThird Reading - Short Debate - Passed 063-043-000 4/1/2022SenatePassed Both Houses 4/29/2022SenateSent to the Governor 5/13/2022SenateGovernor Approved 5/13/2022SenateEffective Date May 13, 2022 5/13/2022SenatePublic Act . . . . . . . . . 102-0879